share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Secora Michael

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Secora Michael

Recursion Pharmaceuticals | 4:持股變動聲明-高管 Secora Michael
美股SEC公告 ·  09/13 06:29

牛牛AI助理已提取核心訊息

Recursion Pharmaceuticals' Chief Financial Officer, Secora Michael, completed a series of stock transactions on September 10 and 11, 2024. The transactions involved the sale of 30,000 shares of Class A Common Stock at prices ranging from $6.1666 to $6.3153 per share, resulting in a total market value of $187,228.50. Additionally, Secora exercised options to acquire 78,750 shares at a price of $2.22 per share. Following these transactions, Secora Michael holds a total of 1,402,131 shares in the company.
Recursion Pharmaceuticals' Chief Financial Officer, Secora Michael, completed a series of stock transactions on September 10 and 11, 2024. The transactions involved the sale of 30,000 shares of Class A Common Stock at prices ranging from $6.1666 to $6.3153 per share, resulting in a total market value of $187,228.50. Additionally, Secora exercised options to acquire 78,750 shares at a price of $2.22 per share. Following these transactions, Secora Michael holds a total of 1,402,131 shares in the company.
Recursion Pharmaceuticals的致富金融(臨時代碼),Secora Michael在2024年9月10日和11日完成了一系列股票交易。這些交易涉及以每股6.1666至6.3153美元的價格出售30,000股A類普通股,總市值爲187,228.50美元。此外,Secora行使期權以2.22美元的價格獲得78,750股股票。在這些交易之後,Secora Michael在公司持有總共1,402,131股股票。
Recursion Pharmaceuticals的致富金融(臨時代碼),Secora Michael在2024年9月10日和11日完成了一系列股票交易。這些交易涉及以每股6.1666至6.3153美元的價格出售30,000股A類普通股,總市值爲187,228.50美元。此外,Secora行使期權以2.22美元的價格獲得78,750股股票。在這些交易之後,Secora Michael在公司持有總共1,402,131股股票。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。